Escherichia coli uropathogenic-specific protein, USP, is a bacteriocin-like genotoxin

Journal of Infectious Diseases

Volumn 208, Issue 10, 2013, Pages 1545-1552

  Nipič, Damijan ^a   Podlesek, Zdravko ^a   Budič, Maruska ^a   Črnigoj, Miha ^a   Žgur Bertok, Darja ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Bacteriocin like; Escherichia coli; Genotoxin; Uropathogenic specific protein

Indexed keywords

ACTIN; BACTERIAL TOXIN; BACTERIOCIN; CASPASE 3; CASPASE 7; DEOXYRIBONUCLEASE; ESCHERICHIA COLI UROPATHOGENIC SPECIFIC PROTEIN; FLUORESCENT DYE; PLASMID DNA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BACTERIAL GENE; CELL ASSAY; CELL STRAIN HEK293; CELL VIABILITY; COMET ASSAY; CONTROLLED STUDY; CYTOCHEMISTRY; CYTOSKELETON; ENZYME ACTIVITY; ESCHERICHIA COLI; GENE ISOLATION; GENOTOXICITY; HUMAN; HUMAN CELL; IMU1-3 GENE; MAMMAL CELL; PRIORITY JOURNAL; UMBILICAL VEIN ENDOTHELIAL CELL; USP GENE; WESTERN BLOTTING;

BACTERIOCIN-LIKE; ESCHERICHIA COLI; GENOTOXIN; UROPATHOGENIC SPECIFIC PROTEIN;

BACTERIOCINS; CASPASES; CELL LINE; CELL SURVIVAL; CYTOSKELETON; DEOXYRIBONUCLEASES; ESCHERICHIA COLI PROTEINS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MUTAGENS;

EID: 84888215316     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jit480     Document Type: Article

References (37)

1. Croxen MA, Finlay BB. Molecular mechanisms of Escherichia coli pathogenicity. Nature Rev Microbiol 2010; 8:26-38.
2. Kohler CD, Dobrindt U. What defines extraintestinal pathogenic Escherichia coli? Int J Med Microbiol 2011; 301:642-7.
3. McBean M, Rajamani S. Increasing rates of hospitalization due to septicemia in the US elderly population, 1986-1997. J Infect Dis 2001; 183:596-603.
4. Yamamoto S, Nakano M, Terai A, et al. The presence of the virulence island containing the USP gene in uropathogenic Escherichia coli is associated with urinary tract infection in an experimental mouse model. J Urol 2001; 165:1347-51.
5. Rijavec M, Muller-Premru M, Zakotnik B, Zgur-Bertok D. Virulence factors and biofilm production among Escherichia coli strains causing bacteraemia of urinary tract origin. J Med Microbiol 2008; 57:1329-34.
6. Parret AHA, De Mot R. Escherichia coli's uropathogenic-specific protein: A bacteriocin promoting infectivity? Microbiology-Sgm 2002; 148:1604-6.
7. Williams SG, Varcoe LT, Attridge SR, Manning PA. Vibrio cholerae Hcp, a secreted protein coregulated with HlyA. Infect Immun 1996; 64:283-9.
8. Mulder DT, Cooper CA, Coombes BK. Type VI secretion system-associated gene clusters contribute to pathogenesis of Salmonella enterica serovar Typhimurium. Infect Immun 2012; 80:1996-2007.
9. Stevens KE, Changb D, Zwack EE, Sebert ME. Competence in Streptococcus pneumoniae is regulated by the rate of ribosomal decoding errors. MBio 2011; 2: pii: e00071-11.
10. Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65:55-63.
11. Zegura B, Sedmak B, Filipic M. Microcystin-LR induces oxidative DNA damage in human hepatoma cell line HepG2. Toxicon 2003; 41:41-8.
12. Singh NP, McCoy MT, Tice RR, Schneider EL. A simple technique for quantitation of low-levels of DNA damage in individual cells. Exp Cell Res 1988; 175:184-91.
13. Zegura B, Dobnik D, Niderl MH, Filipic M. Antioxidant and antigenotoxic effects of rosemary (Rosmarinus officinalis L.) extracts in Salmonella typhimurium TA98 and HepG2 cells. Environ Toxicol Pharmacol 2011; 32:296-305.
14. Coconnier MH, Lorrot M, Barbat A, Laboisse C, Servin AL. Listeriolysin O-induced stimulation of mucin exocytosis in polarized intestinal mucin-secreting cells: evidence for toxin recognition of membraneassociated lipids and subsequent toxin internalization through caveolae. Cell Microbiol 2000; 2:487-504.
15. Pugsley AP. Escherichia coli k12 strains for use in the identification and characterization of colicins. J Gen Microbiol 1985; 131:369-76.
16. Harding M, Kubes P. Innate immunity in the vasculature: interactions with pathogenic bacteria. Curr Opin Microbiol 2012; 15:85-91.
17. Weyermann J, Lochmann D, Zimmer A. A practical note on the use of cytotoxicity assays. Int J Pharm 2005; 288:369-76.
18. Isobe I, Michikawa M, Yanagisawa K. Enhancement of MTT, a tetrazolium salt, exocytosis by amyloid beta-protein and chloroquine in cultured rat astrocytes. Neurosci Lett 1999; 266:129-32.
19. Lee S, Marharjan S, Jung JW, et al. Novel human umbilical vein endothelial cells (HUVEC)-apoptosis inhibitory phytosterol analogues: insight into their structure-activity relationships. Arch Pharm Res 2012; 35:455-60.
20. Simák J, Holada K, Vostal JG. Release of annexin V-binding membrane microparticles from cultured human umbilical vein endothelial cells after treatment with camptothecin. BMC Cell Biol 2002; 3:11-21.
21. Sepehri S, Khafipour E, Bernstein CN, et al. Characterization of Escherichia coli isolated from gut biopsies of newly diagnosed patients with inflammatory bowel disease. Inflamm Bowel Dis 2011; 17:1451-63.
22. Oswald E, Nougayrede JP, Taieb F, Sugai M. Bacterial toxins that modulate host cell-cycle progression. Curr Opin Microbiol 2005; 8: 83-91.
23. Lemonnier M, Landraud L, Lemichez E. Rho GTPase-activating bacterial toxins: from bacterial virulence regulation to eukaryotic cell biology. FEMS Microbiol Rev 2007; 31:515-34.
24. Marchès O, Ledger TN, Boury M, et al. Enteropathogenic and enterohaemorrhagic Escherichia coli deliver a novel effector called Cif, which blocks cell cycle G2/M transition. Mol Microbiol 2003; 50:1553-67.
25. Johnson WM, Lior H. Production of Shiga toxin and a cytolethal distending toxin (CLDT) by serogroups of Shigella spp. FEMS Microbiol Lett 1987; 48:227-30.
26. Guerra L, Guidi R, Frisan T. Do bacterial genotoxins contribute to chronic inflammation, genomic instability and tumor progression? Febs Journal 2011; 278:4577-88.
27. Jinadasa RN, Bloom SE, Weiss RS, Duhamel GE. Cytolethal distending toxin: A conserved bacterial genotoxin that blocks cell cycle progression, leading to apoptosis of a broad range of mammalian cell lineages. Microbiology- Sgm 2011; 157:1851-75.
28. Elwell CA, Dreyfus LA. DNase I homologous residues in CdtB are critical for cytolethal distending toxin-mediated cell cycle arrest. Mol Microbiol 2000; 37:952-63.
29. Lara-Tejero M, Galan JE. A bacterial toxin that controls cell cycle progression as a deoxyribonuclease I-like protein. Science 2000; 290:354-7.
30. Nougayrède JP, Homburg S, Taieb F, et al. Escherichia coli induces DNA double-strand breaks in eukaryotic cells. Science 2006; 313:848-51.
31. Putze J, Hennequin C, Nougayrede JP, et al. Genetic structure and distribution of the colibactin genomic island among members of the family Enterobacteriaceae. Infect Immun 2009; 77:4696-703.
32. Elmore S. Apoptosis: A review of programmed cell death. Toxicol Pathol 2007; 35:495-516.
33. Ubeda C, Maiques E, Knecht E, Lasa I, Novick RP, Penadés JR. Antibiotic- induced SOS response promotes horizontal dissemination of pathogenicity island-encoded virulence factors in staphylococci. Mol Microbiol 2005; 56:836-44.
34. Jänicke RU, Sprengart M, Wati MR, Porter AG. Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J Biol Chem 1998; 273:9357-60.
35. Nakano M, Yamamoto S, Terai A, et al. Structural and sequence diversity of the pathogenicity island of uropathogenic Escherichia coli which encodes the USP protein. FEMS Microbiol Lett 2001; 205: 71-6.
36. Kanamaru S, Kurazono H, Nakano M, Terai A, Ogawa O, Yamamoto S. Subtyping of uropathogenic Escherichia coli according to the pathogenicity island encoding uropathogenic-specific protein: Comparison with phylogenetic groups. Int J Urol 2006; 13:754-60.
37. Tan Y, Riley M. Positive selection and recombination: major molecular mechanisms in colicin diversification. Trends Ecol Evol 1997; 12: 348-51.